Life SciencesLiability

Question

What is the difference between umbrella and excess liability for life sciences operators?

Short answer

Umbrella is broader: it adds limits over scheduled underlying policies and can drop down to fill gaps where an underlying policy does not respond. Excess (follow-form excess) only adds limits over a specific underlying policy and follows its exact terms. For life sciences operators stacking large products towers, the distinction matters most in whether the higher layers truly follow form over products and completed operations.

Umbrella liability

An umbrella policy provides additional limits over multiple scheduled underlying policies - typically general liability, auto, and employers liability - and, because it is its own policy form, can in some cases drop down to cover a claim that an underlying policy excludes or that falls into a gap, subject to a self-insured retention. The umbrella is the more flexible of the two structures.

In practice, umbrellas still contain their own exclusions, so the "drops down to cover gaps" benefit is real but bounded. The schedule of underlying policies defines what the umbrella sits over.

Excess (follow-form) liability

A follow-form excess policy adds limits over a single specified underlying policy and adopts that policy's terms, conditions, and exclusions exactly - it "follows the form." It does not drop down to fill gaps; if the underlying policy would not respond, the follow-form excess will not either. Its job is purely to extend the limit of the policy beneath it.

Excess layers are the standard way to build a tall tower above an umbrella - for example, a $1M/$2M primary, then a $5M umbrella, then a $10M follow-form excess over the umbrella, to reach a $15M+ total.

Why this matters for the products tower

Life sciences operators frequently need large products and completed operations towers to satisfy sponsor and hospital contracts. Those towers are built in layers, and the load-bearing question is whether every layer follows form over products and completed operations. A tower that follows form over products on the umbrella but reverts to narrower wording on a higher excess layer leaves the operator with limit on paper but a potential coverage gap at the exact catastrophic severity the tower was bought to cover.

This is the detail that separates a tower that responds at a real FDA Class I recall or a multi-claimant products event from one that does not. It is confirmed by reading each layer's follow-form status against the primary products wording.

Which structure operators use

Most life sciences operators use a hybrid: a primary, an umbrella for breadth and the first chunk of excess limit, and follow-form excess layers above the umbrella to reach the total the contracts require. Smaller operators with modest contract requirements may need only a primary plus an umbrella. Operators with $15M-$25M+ requirements will stack multiple excess layers, and each layer's terms relative to products and completed operations should be verified.

Primary sources

Sources and references

This answer draws on the following regulatory, statutory, and standards-body sources. Coverage availability and program structure also depend on carrier appetite and underwriter discretion not captured by these sources.

Related practice areas

Insurance clauses in this area

Related questions

Have a more specific question?

A specialist will reach out by the end of the day.

Request a free coverage review

Free coverage review

A specialist will reach out by the end of the day.

Request the review

A specialist will reach out by the end of the day.

Your details only schedule the review. No marketing sequences, no list rental.